These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18813016)

  • 1. The sound and the fury: was it all worth it?
    Hoover RN
    Epidemiology; 2008 Nov; 19(6):780-2; discussion 789-93. PubMed ID: 18813016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ITT for observational data: worst of both worlds?
    Stampfer MJ
    Epidemiology; 2008 Nov; 19(6):783-4; discussion 789-93. PubMed ID: 18813017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial.
    Prentice RL; Langer R; Stefanick ML; Howard BV; Pettinger M; Anderson G; Barad D; Curb JD; Kotchen J; Kuller L; Limacher M; Wactawski-Wende J;
    Am J Epidemiol; 2005 Sep; 162(5):404-14. PubMed ID: 16033876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmenopausal hormone therapy before and after the women's health initiative study: what consequences?
    Mikkola TS; Clarkson TB; Notelovitz M
    Ann Med; 2004; 36(6):402-13. PubMed ID: 15513292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What can we learn from design faults in the Women's Health Initiative randomized clinical trial?
    Tan O; Harman SM; Naftolin F
    Bull NYU Hosp Jt Dis; 2009; 67(2):226-9. PubMed ID: 19583558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials.
    Anderson GL; Kooperberg C; Geller N; Rossouw JE; Pettinger M; Prentice RL
    Clin Trials; 2007; 4(3):207-17. PubMed ID: 17715246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease.
    Hernán MA; Alonso A; Logan R; Grodstein F; Michels KB; Willett WC; Manson JE; Robins JM
    Epidemiology; 2008 Nov; 19(6):766-79. PubMed ID: 18854702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Observational studies and clinical trials of menopausal hormone therapy: can they both be right?
    Allison MA; Manson JE
    Menopause; 2006; 13(1):1-3. PubMed ID: 16607089
    [No Abstract]   [Full Text] [Related]  

  • 9. Monitoring the randomized trials of the Women's Health Initiative: the experience of the Data and Safety Monitoring Board.
    Wittes J; Barrett-Connor E; Braunwald E; Chesney M; Cohen HJ; Demets D; Dunn L; Dwyer J; Heaney RP; Vogel V; Walters L; Yusuf S
    Clin Trials; 2007; 4(3):218-34. PubMed ID: 17715247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How we got to the Women's Health Initiative hormone replacement trial.
    Gambone JC
    J Am Osteopath Assoc; 2003 Feb; 103(2 Suppl 2):S1-2. PubMed ID: 12625630
    [No Abstract]   [Full Text] [Related]  

  • 11. Statistical issues arising in the Women's Health Initiative.
    Prentice RL; Pettinger M; Anderson GL
    Biometrics; 2005 Dec; 61(4):899-911; discussion 911-41. PubMed ID: 16401257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invited commentary: hormone therapy and risk of coronary heart disease why renew the focus on the early years of menopause?
    Manson JE; Bassuk SS
    Am J Epidemiol; 2007 Sep; 166(5):511-7. PubMed ID: 17646204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone therapy and cardiovascular disease in the early postmenopause: the WHI data revisited.
    Pines A; Sturdee DW; Birkhäuser MH;
    Climacteric; 2007 Jun; 10(3):195-6. PubMed ID: 17487646
    [No Abstract]   [Full Text] [Related]  

  • 14. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Bittner V
    Expert Opin Pharmacother; 2009 Sep; 10(13):2041-53. PubMed ID: 19563274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy and cardiovascular disease revisited.
    Stevenson JC
    Menopause Int; 2009 Jun; 15(2):55-7. PubMed ID: 19465669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gynecologists and estrogen: an affair of the heart.
    Fugh-Berman A; Scialli AR
    Perspect Biol Med; 2006; 49(1):115-30. PubMed ID: 16489281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy post Women's Health Initiative study: where do we stand?
    Calleja-Agius J; Brincat MP
    Curr Opin Obstet Gynecol; 2008 Dec; 20(6):513-8. PubMed ID: 18989125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can menopausal hormone therapy prevent coronary heart disease?
    Brinton EA; Hodis HN; Merriam GR; Harman SM; Naftolin F
    Trends Endocrinol Metab; 2008 Aug; 19(6):206-12. PubMed ID: 18450469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observational data and clinical trials: narrowing the gap?
    Wilcox A; Wacholder S
    Epidemiology; 2008 Nov; 19(6):765. PubMed ID: 18854701
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.